Update in the Reversal of Oral Anticoagulants: New Developments and Clinical Strategies

Jointly provided by Postgraduate Institute for Medicine and CMEology.

PIM

This activity is supported by an independent education grant from Baxalta US Inc.

Scroll to the Bottom of this Information to Begin this Course

Release date: October 2015

Valid through: October 2016

Media: Internet

Estimated Time to Complete Activity: 1.25 hours

Target Audience

This activity has been designed to meet the educational needs of healthcare providers, including physicians and registered nurses, who manage patients undergoing treatment with anticoagulant therapies.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Apply strategies for reversal of vitamin K antagonist anticoagulants
  • Apply strategies for reversal of direct thrombin inhibitors and factor Xa inhibitors
  • Differentiate among the prothrombin complex concentrates and their use in anticoagulant reversal
  • Provide appropriate care and counsel for patients and their families

Credit Available

  • Physicians — maximum of 1.25 AMA PRA Category 1 Credits
  • Nurses1.1 contact hours

All other healthcare professionals completing this course will be issued a statement of participation.

Faculty

Sam Schulman, MD, PhD, FRCPC(C) – Chairperson
Professor, Department of Medicine
McMaster University

Director, Clinical Thromboembolism Program
Hamilton Health Sciences - General Hospital
Hamilton, Ontario, Canada

Associate Professor, Medicine
Karolinska Institute
Stockholm, Sweden

Marcel Levi, MD, PhD
Professor of Medicine
Dean, Faculty of Medicine
University of Amsterdam

Chairman, Department of Medicine
Academic Medical Center of the University of Amsterdam
Amsterdam, the Netherlands

Yulia Lin, MD, FRCPC
Transfusion Medicine & Hematology
Sunnybrook Health Sciences

Assistant Professor
Department of Laboratory Medicine and Pathobiology
University of Toronto
Toronto, Ontario, Canada

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and CMEology. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

This educational activity for 1.1 contact hours is provided by Postgraduate Institute for Medicine.

Accreditation Statement

Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Disclosures of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Marcel Levi, MD
  • No financial relationships to report.
Yulia Lin, MD, FRCPC
  • Consulting Fees (e.g., advisory boards): Genzyme Corporation, Boehringer Ingelheim
  • Contracted Research: GlaxoSmithKline
Sam Schulman, MD, PhD, FRCPC(C)
  • Consulting Fees (e.g., advisory boards): Boehringer Ingelheim, Bayer AG, Bristol-Myers Squibb Company
  • Contracted Research: Boehringer Ingelheim, Octapharma AG, Baxter Healthcare Corporation

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, MSN, RN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following CMEology planners and managers, Rob Lowney, Dana Ravyn, PhD, MPH, and Rachael Soranno  hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this activity. During the period October 2015 through October 2016, participants must read the learning objectives and faculty disclosures and study the educational activity. . If you pass the post-test and complete the evaluation, your certificate will be available immediately for download in PDF format.

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.